Skip to main content

Home/ Cancer/ Group items matching "OncoVEX" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

BioVex To Announce Updated Survival Data From A Phase II Clinical Study Of OncoVEX GM-CSF In Metastatic Melanoma - 0 views

www.medicalnewstoday.com/...150301.php

2009 May medicalnewstoday news cancer metastatic melanoma phase_II trial BioVex ASCO GM-CSF oncolytic herpes virus oncolytic_virus oncolytic_viruses viruses OncoVEX experimental treatment therapy virotherapy Survival Data

shared by Matti Narkia on 24 May 09 - Cached
  • Matti Narkia on 24 May 09
     
    BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced that updated survival data from its Phase II study in metastatic melanoma will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 29, 2009 - June 2, 2009 in Orlando, F
Matti Narkia

BioVex To Report Phase I/II Clinical Trial Results For The Front Line Treatment Of Head And Neck Cancer - 0 views

www.medicalnewstoday.com/...150300.php

2009 May medicalnewstoday news head_and:neck cancer head_and:neck_cancer hnca scchn scc ASCO meeting OncoVEX GM-CSF chemoradiotherapy OncoVEX_GM-CSF BioVex oncolytic_virus oncolytic_viruses oncolytic virus viruses virotherapy phase_I phase_II trial

shared by Matti Narkia on 16 May 09 - Cached
  • Matti Narkia on 16 May 09
     
    BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced that the results from a Phase I/II combination study in previously untreated patients with head and neck cancer will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29, 2009 - June 2, 2009 in Orlando, FL.
1 - 2 of 2
Showing 20▼ items per page